Cervical Cancer Clinical Trials in Guangzhou, Guangdong
10 recruitingGuangzhou, Guangdong, China
Showing 1–10 of 10 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled239 locationsNCT06459180
Recruiting
Phase 2
QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial
Neoadjuvant Treatment for Locally Advanced Cervical Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University50 enrolled1 locationNCT07286253
Recruiting
A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
Ovarian Cancer RecurrentEndometrial Cancer RecurrentCervical Cancer Recurrent
Sun Yat-sen University200 enrolled2 locationsNCT06781151
Recruiting
Phase 2
Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
Cervical Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34 enrolled1 locationNCT07003620
Recruiting
Not Applicable
Modified Tumor-free Techniques Operation to Cervical Cancer
Cervical Cancer Stage IB2
Peking Union Medical College Hospital524 enrolled13 locationsNCT06836869
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.200 enrolled24 locationsNCT06799637
Recruiting
Phase 2
Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Cervical Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University29 enrolled1 locationNCT06511726
Recruiting
Phase 2
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Cervical CancerFertility PreservationNeoadjuvant Chemoimmunotherapy
Tongji Hospital40 enrolled2 locationsNCT06289062
Recruiting
Phase 1Phase 2
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Breast CancerLiver CancerColorectal, Cancer+8 more
Second Affiliated Hospital of Guangzhou Medical University100 enrolled1 locationNCT05187338
Recruiting
Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery
cfHPV DNA in Plasma of Cervical Cancer Patients
The Third Affiliated Hospital of Guangzhou Medical University150 enrolled1 locationNCT06420427